Nu tu arī meklē tikai caur rozā brillēm, ir jāmeklē vispirms sliktais. Kad izvēlies, kādu framwork, priekš programmēšanas vienmēr skaties uz slikto, ja sliktais tev neliekas pieņemams risks, tad neizvēlies. Pozitīvais reti, kad atsver negatīvo, zāles dzerot tu bojā citas sava ķermeņa daļas.
Tikai palasi viņu pašu web ielikto info:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1480510/
Retha R. Newbold, a supervisory research biologist at the NIEHS, is well aware of these factors. Concerns about genistein’s effects on reproduction and development are due in part to her extensive research in mice. Newbold believes caution is warranted, because her studies, as well as others, have shown that genistein has such effects as inducing uterine adenocarcinoma in mice and premature puberty in rats. A recent study led by biologist Wendy Jefferson in Newbold’s laboratory and published in the October 2005 issue of Biology of Reproduction linked genistein with effects such as abnormal estrous cycle, altered ovarian function, and infertility in mice.
Given the limited evidence for the health effects of soy isoflavones in infants, pediatric and health organizations in several countries suggest caution in feeding soy to infants and young children. If an infant is not receiving breast milk (either its mother’s or a donor’s), cow’s milk–based infant formula is the first recommendation. If there seems to be a problem with that option, parents shouldn’t automatically switch to soy formula, assuming dairy allergy or lactose intolerance. Soybeans are a major allergen, and a significant percentage of children who are sensitive to dairy are also sensitive to soy.
Un pozitīvās īpašības anv nemaz tik ļoti spēcīgas, kā jūs te klārējat:
On balance it does not seem that soy and its constituent isoflavones have met original expectations. Clinical results with regard to soy’s ability to reduce the risk of cardiovascular disease have been inconsistent; a review in the 21 February 2006 issue of Circulation indicated there was little to no effect. The only apparent impact of soy and soy isoflavones on cardiovascular disease risks seems to be a slight reduction in low-density lipoproteins in individuals who had very high levels of cholesterol. An August 2005 report from the DHHS Agency for Healthcare Research and Quality, Effects of Soy on Health Outcomes, also concluded that there was little evidence to support a beneficial role of soy and soy isoflavones in bone health, cancer, reproductive health, neurocognitive function, and other health parameters.
What most researchers do agree on is that we are only just beginning to truly understand the nature of soy, and that much more research is needed before it is possible to make firm health recommendations.
Kad viņiem būs visi pētījumi, tad arī runāsim.
http://www.ncbi.nlm.nih.gov/pubmed/7892297
http://www.ncbi.nlm.nih.gov/pubmed/10828262
Kuram, no viņu pētījumiem man ticēt.... Tiem, kas saka, ka soja ir laba vai tiem, ka saka slikta, vai trešiem, kas saka ka nezina. Labāk, turpināšu viņu nelietot.
http://www.ncbi.nlm.nih.gov/pubmed/15047678
http://www.ncbi.nlm.nih.gov/pubmed/22449212
http://www.ncbi.nlm.nih.gov/pubmed/3361685
Labāk ticēšu ārstam un ignorēšu šarlatānus šeit.
https://www.youtube.com/watch?v=w8W9kTQgXQ0